An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Academic Journal of Biosciences | Volume-4 | Issue-05
Terlipressin Induced Severe Symptomatic Reversible Septal Coronary Artery Spasm in Hepato-Renal Syndrome
Cyriac Abby Philips MD , Shakti Prasad Choudhury MD
Published: May 30, 2016 | 138 140
DOI: 10.36347/sajb.2016.v04i05.006
Pages: 396-398
Downloads
Abstract
Terlipressin is a long acting vasopressin analogue used in cirrhosis patients for management of hepatorenal syndrome and variceal bleeding. Terlipressin is not without side effects and sometimes, life threatening complications do occur. Here we present a cirrhotic patient who, after receiving Terlipressin developed reversible cardiac ischemia, documented real time on electrocardiography.